Login / Signup

Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study.

Junyan WuJianxiang HuangJianhong ZhuZhichao HeMengting ChenSiyuan GaoDan LiangXiaoxia YuChengyu Lu
Published in: Expert opinion on drug safety (2022)
ICIs may increase the risk of KTR in organ transplant recipients with cancer.
Keyphrases
  • papillary thyroid
  • squamous cell
  • emergency department
  • adverse drug
  • squamous cell carcinoma
  • drug induced
  • lymph node metastasis